Citation Impact
Citing Papers
Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases
2007
Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
2011
Probing the Probes: Fitness Factors For Small Molecule Tools
2010
Molecular Pathways: Targeting Hsp90—Who Benefits and Who Does Not
2012
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
2015
The molecular hallmarks of epigenetic control
2016 Standout
Gastric Stromal Sarcoma, Pulmonary Chondroma, and Extra-adrenal Paraganglioma (Carney Triad): Natural History, Adrenocortical Component, and Possible Familial Occurrence
1999
Expression of Angiogenic Growth Factors in Paragangliomas
2000
The Spliceosome: Design Principles of a Dynamic RNP Machine
2009 Standout
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
2011
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
RB and cell cycle progression
2006 Standout
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP
2007
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
2006
Targeting apoptosis in cancer therapy
2020 Standout
The Collagen Family
2010 Standout
Are RB proteins a potential substrate of Pin1 in the regulation of the cell cycle?
2005
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
2007
Epigenetic protein families: a new frontier for drug discovery
2012
Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity
2007
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
2013
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
2014
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
2013 StandoutNobel
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Tumour-microenvironmental interactions: paths to progression and targets for treatment
2010
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α
2016
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Toll-Like Receptor Signaling Pathways
2014 Standout
Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1
2006
The Biosynthetic Logic of Polyketide Diversity
2009 Standout
Emerging targeted agents in metastatic breast cancer
2013
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Ynamides: A Modern Functional Group for the New Millennium
2010 Standout
Biology of Gastrointestinal Stromal Tumors
2004 Standout
PHD2 inactivation in Type I cells drives HIF‐2α‐dependent multilineage hyperplasia and the formation of paraganglioma‐like carotid bodies
2018 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
2015
Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
2010
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
2011 Standout
Association of Cancer History with Alzheimer’s Disease Dementia and Neuropathology
2016
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Analysis of nanoparticle delivery to tumours
2016 Standout
A Sequential Metal-Catalyzed C−N Bond Formation in the Synthesis of 2-Amido-indoles
2008
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Identification of Fredericamycin E from Streptomyces griseus: Insights into Fredericamycin A Biosynthesis Highlighting Carbaspirocycle Formation
2008
Works of Da-Gong Wang being referenced
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2012
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2010
Oncogene expression in carotid body tumors
1996
Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers
2004
Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer
2009
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
2009
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
2003